Mostrar el registro sencillo del ítem

Artículo

dc.creatorCastejón Martínez, María Luisaes
dc.creatorAlarcón de la Lastra Romero, Catalinaes
dc.creatorRosillo Ramírez, María de los Ángeleses
dc.creatorMontoya García, Tatianaes
dc.creatorFernández-Bolaños Guzmán, José Maríaes
dc.creatorGonzález Benjumea, Alejandroes
dc.creatorSánchez Hidalgo, Marinaes
dc.date.accessioned2021-02-23T08:37:42Z
dc.date.available2021-02-23T08:37:42Z
dc.date.issued2021-01
dc.identifier.citationCastejón Martínez, M.L., Alarcón de la Lastra Romero, C., Rosillo Ramírez, M.d.l.Á., Montoya García, T., Fernández-Bolaños Guzmán, J.M., González Benjumea, A. y Sánchez Hidalgo, M. (2021). A New Peracetylated Oleuropein Derivative Ameliorates Joint Inflammation and Destruction in a Murine Collagen-Induced Arthritis Model via Activation of the Nrf-2/Ho-1 Antioxidant Pathway and Suppression of MAPKs and NF-κB Activation. Nutrients, 13 (2), 311. https://doi.org/10.3390/nu13020311.
dc.identifier.issn2072-6643es
dc.identifier.urihttps://hdl.handle.net/11441/105286
dc.description.abstractOleuropein (OL), an olive tree secoiridoid and its peracetylated derivate (Per-OL) haveexhibited several beneficial effects on LPS-stimulated macrophages and murine experimental sys-temic lupus erythematosus (SLE). This study was designed to evaluate dietary Per-OL in comparisonwith OL supplementation effects on collagen-induced arthritis (CIA) murine model. Three-weeks-old DBA-1/J male mice were fed from weaning with a standard commercial diet or experimentalenriched-diets in 0.05 % (w/w) OL, 0.05% and 0.025% Per-OL. After six weeks of pre-treatment, arthri-tis was induced by bovine collagen type II by tail base injection (day 0) and on day 21, mice received abooster injection. Mice were sacrificed 42 days after the first immunization. Both Per-OL and OL dietssignificantly prevented histological damage and arthritic score development, although no statisticallysignificant differences were observed between both compounds. Also, serum collagen oligomericmatrix protein (COMP), metalloprotease (MMP)-3 and pro-inflammatory cytokines levels were ame-liorated in paws from secoiridoids fed animals. Mitogen-activated protein kinases (MAPK)s andnuclear transcription factor-kappa-B (NF-κB) activations were drastically down-regulated whereasnuclear factor E2-related factor 2 (Nrf2) and heme-oxygenase-1 (HO-1) protein expressions wereup-regulated in those mice fed with OL and Per-OL diets. We conclude that both Per-OL and itsparent compound, OL, supplements might provide a basis for developing a new dietary strategy forthe prevention of rheumatoid arthritis.es
dc.description.sponsorshipMinisterio de Economía y Competitividad de España-AG2017-89342-Pes
dc.description.sponsorshipDirección General de Investigación de España-CTQ2016-78703-Pes
dc.description.sponsorshipJunta de Andalucía y Fondo Europeo de Desarrollo Regional (FEDER)-CTS259 y FQM134es
dc.description.sponsorshipVI Plan Propio de Investigación y Transferencia de la Universidad de Sevillaes
dc.formatapplication/pdfes
dc.format.extent14 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofNutrients, 13 (2), 311.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectarthritises
dc.subjectCIAes
dc.subjectinflammationes
dc.subjectMAPKes
dc.subjectNF-κBes
dc.subjectNrf2/HO1es
dc.subjectoleuropeines
dc.titleA New Peracetylated Oleuropein Derivative Ameliorates Joint Inflammation and Destruction in a Murine Collagen-Induced Arthritis Model via Activation of the Nrf-2/Ho-1 Antioxidant Pathway and Suppression of MAPKs and NF-κB Activationes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Farmacologíaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Ingeniería Químicaes
dc.relation.projectIDAG2017-89342-Pes
dc.relation.projectIDCTQ2016-78703-Pes
dc.relation.projectIDCTS259es
dc.relation.projectIDFQM134es
dc.relation.publisherversionhttps://doi.org/10.3390/nu13020311es
dc.identifier.doi10.3390/nu13020311es
dc.contributor.groupUniversidad de Sevilla. CTS259: Farmacología Experimental y Farmacia Clínicaes
dc.contributor.groupUniversidad de Sevilla. FQM134: Química Fina de Carbohidratoses
dc.journaltitleNutrientses
dc.publication.volumen13es
dc.publication.issue2es
dc.publication.initialPage311es
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). Españaes
dc.contributor.funderDirección General de Investigación (DGI). Españaes
dc.contributor.funderJunta de Andalucíaes
dc.contributor.funderEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)es
dc.contributor.funderUniversidad de Sevillaes

FicherosTamañoFormatoVerDescripción
nutrients-13-00311-v2.pdf3.943MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional